Very-low-carbohydrate diets can improve blood sugar control in type 1 diabetes, with low rates of hypoglycemia and other complications, according to an online patient survey. The researchers now call for controlled clinical trials of this approach.
Scientists working with laboratory mice have shown that it’s possible to favor the engraftment of one gut bacterial strain over others by manipulating the mice’s diet. The researchers also have shown it’s possible to control how much a bacterium grows in the intestine by calibrating the amount of a specific carbohydrate in each mouse’s water or food.
If you’ve been following the Bulletproof Diet, or looking for a way to burn more fat on a healthy, whole food diet, you may have come across CLA, or conjugated linoleic acid. It’s one of the magic ingredients that make grass-fed butter and meat so incredible for boosting your physical performance. As one of the […]
A new study has determined that protein intake from solid foods has a significant impact on infant growth during the first year of life. The study tested whether dairy-based or meat-based protein in an infant’s diet contributed to growth and weight gain.
For years, doctors have associated the BRCA1 and BRCA2 gene mutations with an increased risk of breast cancer. But researchers have now identified another gene that may have an impact on breast cancer –associated with the body’s circadian rhythm.
An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet. Inadvertent exposure to gluten can be a frequent occurrence for celiac patients that triggers symptoms, such as pain in the gut and diarrhea, due to intestinal damage.
Source: Experimental drug eases effects of gluten for celiac patients on gluten-free diet: First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure — ScienceDaily
A new study identifies a pattern of inflammation associated with cardio-metabolic risks among participants in the Black Women’s Health Study, as well as two independent groups of vulnerable women. These findings could help under-served patients benefit from precision medicine and personalized profiles of disease risk.